WHAT IS 1V-LSD?
1V-LSD (1-valeroyl-lysergic acid diethylamide hemi-L-tartrate), or simply ‘Valerie’, is the latest lysergamide and prodrug derivative of LSD
to hit the research chemical market. 1V-LSD is homologous to 1P-LSD, containing a valeroyl group bound to the indole nitrogen instead of a propionyl group. Due to the high lipophilicity of the valeroyl group there is now a great opportunity to study the potentially unique pharmacokinetic properties of this novel compound.
WHAT IS A PRODRUG?
A prodrug is a molecule with little or no pharmacological activity that is converted into an active parent molecule in-vivo by enzymatic or chemical reactions, or by a combination of the two. In the case of 1V-LSD, 1cP-LSD, 1P-LSD, and 1B-LSD, these are prodrugs of LSD. This means that living organisms, such as animals, can convert them into LSD if consumed. Please note, however, that all products sold on 1VLSD.COM
are strictly for research purposes only and we do not condone or support in-vivo use.
1V-LSD VS 1CP-LSD
1V-LSD is very similar to 1cP-LSD as it is also a prodrug of LSD. Although some report 1V-LSD to be more visual than 1cP-LSD, for research purposes, it can be considered as an identical replacement. Moreover, Valerie was created with global NPS legislations in mind; meaning that it is legal in almost all countries, including Germany.